| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
77.86(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$274.66 - $556.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 13.6 |
| Insider 6 Months : 13.6 |
| Insider 3/6 Months : 27.7 |
|
| Guru Rank Number : 10 |
| Guru Rank Value : 25.7 |
| Guru Occurances : 5 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
8,500 |
8,500 |
8,500 |
8,500 |
| Total Buy Value |
$2,438,951 |
$2,438,951 |
$2,438,951 |
$2,438,951 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
0 |
8,535 |
15,952 |
103,127 |
| Total Sell Value |
$0 |
$3,521,612 |
$6,726,794 |
$50,942,872 |
| Total People Sold |
0 |
3 |
3 |
9 |
| Total Sell Transactions |
0 |
3 |
4 |
16 |
| End Date |
2025-05-18 |
2025-02-14 |
2024-08-16 |
2023-08-17 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Collis Steven H |
Director |
– • – |
2025-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
639 |
639 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2025-07-18 |
4 |
B |
$286.07 |
$2,438,951 |
D/D |
8,500 |
151,020 |
2.81 |
7% |
|
| Jallal Bahija |
Director |
– • – |
2025-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
601 |
4,788 |
|
- |
|
| Peru Ramiro G |
Director |
– • – |
2025-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
601 |
9,345 |
|
- |
|
| Strable-Soethout Deanna D |
Director |
– • – |
2025-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
601 |
1,646 |
|
- |
|
| Neri Antonio F |
Director |
– • – |
2025-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
601 |
4,925 |
|
- |
|
| Schneider Ryan M. |
Director |
– • – |
2025-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
601 |
6,600 |
|
- |
|
| Dixon Robert L Jr |
Director |
– • – |
2025-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
601 |
10,322 |
|
- |
|
| Devore Susan D. |
Director |
– • – |
2025-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
601 |
2,302 |
|
- |
|
| Clark R Kerry |
Director |
– • – |
2025-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
601 |
9,640 |
|
- |
|
| Hay Lewis III |
Director |
– • – |
2025-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
601 |
11,507 |
|
- |
|
| Kaye Mark |
EVP & CFO |
• – – |
2025-04-24 |
4 |
S |
$424.82 |
$1,949,074 |
D/D |
(4,588) |
18,977 |
|
31% |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2025-03-10 |
4 |
S |
$415.13 |
$183,903 |
D/D |
(443) |
1,847 |
|
32% |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2025-03-05 |
4 |
S |
$396.30 |
$1,388,635 |
D/D |
(3,504) |
10,116 |
|
15% |
|
| Norwood Felicia F |
EVP & President,Gov Health Ben |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,248 |
31,939 |
|
- |
|
| Norwood Felicia F |
EVP & President,Gov Health Ben |
• – – |
2025-03-03 |
4 |
D |
$395.50 |
$1,033,442 |
D/D |
(2,613) |
24,691 |
|
- |
|
| Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,248 |
26,004 |
|
- |
|
| Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
• – – |
2025-03-03 |
4 |
D |
$395.50 |
$902,136 |
D/D |
(2,281) |
18,756 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,531 |
13,620 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2025-03-03 |
4 |
D |
$395.50 |
$878,406 |
D/D |
(2,221) |
7,089 |
|
- |
|
| Lavu Ratnakar |
EVP, Chief Digital & Info Off |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,339 |
4,783 |
|
- |
|
| Lavu Ratnakar |
EVP, Chief Digital & Info Off |
• – – |
2025-03-03 |
4 |
D |
$395.50 |
$123,396 |
D/D |
(312) |
2,444 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
706 |
2,290 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2025-03-03 |
4 |
D |
$395.50 |
$78,309 |
D/D |
(198) |
1,584 |
|
- |
|
| Kaye Mark |
EVP & CFO |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,604 |
23,565 |
|
- |
|
565 Records found
|
|
Page 1 of 23 |
|
|
14.14 (4.79%) 
